🚀 Special offer for our LEVITY audience: Join Vitalism today and receive a 30% discount on your membership using the code LEVITY at checkout. https://www.vitalism.io/membership#mobilize-sign-up

🚀 Show notes for this episode will be available Wednesday Oct 2. Sign up for the LEVITY newsletter to get them straight to your inbox: https://peterottsjo.beehiiv.com/

Longevity superstar Bryan Johnson made waves when he traveled to the Bahamas for a stem cell treatment. But who's behind this cutting-edge therapy? Meet Maria Rankka, co-founder of Cellcolabs, the Swedish startup that's caught the attention of one of the world's biggest longevity influencers.

In this episode of LEVITY, hosts Peter Ottsjö and Patrick Linden dive deep into Cellcolabs' ambitious mission: to revolutionize healthcare by producing cheap and abundant mesenchymal stromal cells (MSCs). Could this be the key to combating inflammation and extending healthspan on a global scale?

Maria Rankka shares the inside story of Cellcolabs' journey, from its inception during the COVID-19 pandemic to its current position at the forefront of regenerative medicine.

Learn about:

✅ The science behind MSCs and why they're creating buzz in longevity circles

✅ Cellcolabs' innovative approach to scaling stem cell production

✅ Maria's personal experience with MSC treatment

✅ The potential of MSCs to transform preventative medicine

✅ Making regenerative treatments accessible to the masses

Hosted on Acast. See acast.com/privacy for more information.